Kevin Patrick Moran - SVP, Vanda Pharmaceuticals Inc

As of July 30, 2021


Kevin Patrick Moran Net Worth

  • Net worth is estimated to be at least $1.4M
  • Owns at least 99,931 units of Vanda Pharmaceuticals Inc stock
  • Sold an estimated value of $212.94K in the last year at Vanda Pharmaceuticals Inc

Kevin Patrick Moran Compensation at Vanda Pharmaceuticals Inc in 2020

  • Earned a $324,693 salary and a $NaN bonus
  • Rewarded $331,101 in stock value and options
  • Received a total compensation of $1,319,699

Kevin Patrick Moran Trading

  • Largest sale of shares was 9,371 units , worth over $171.97K on March 3, 2021
  • In total has made about 4 transactions over a year
  • Usually trades in July, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Kevin Patrick Moran Mailing Address

  • Mailing address is C/o Vanda Pharmaceuticals Inc. 2200 Pennsylvania Avenue, Suite 300e Washington DC 20037 DC

Vanda Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mihael H. Polymeropoulos, M.D. 2020 $746,235 $ $679,200 $795,830 $656,687 $35,468 $2,913,420
Mihael H. Polymeropoulos, M.D. 2019 $721,000 $ $1,237,200 $1,610,154 $675,000 $34,783 $4,278,137
Mihael H. Polymeropoulos, M.D. 2018 $700,000 $ $1,131,000 $1,456,406 $700,000 $37,322 $4,024,728
James P. Kelly 2020 $124,057 $ $ $ $ $16,217 $140,274
James P. Kelly 2019 $493,370 $ $618,600 $805,077 $288,622 $42,741 $2,248,410
James P. Kelly 2018 $479,000 $ $754,000 $832,232 $299,375 $36,778 $2,401,385
Kevin Moran 2020 $324,693 $ $331,101 $427,779 $200,000 $36,126 $1,319,699
Joakim Wijkstrom 2020 $506,422 $ $339,600 $397,915 $250,679 $29,269 $1,523,885
Aranthan "AJ" Jones II 2020 $406,104 $ $339,600 $397,915 $201,021 $33,677 $1,378,317
Timothy Williams 2020 $400,000 $ $339,600 $397,915 $200,000 $41,546 $1,379,061
Timothy Williams 2019 $379,315 $ $618,600 $805,077 $177,520 $42,342 $2,022,854
Timothy Williams 2018 $144,886 $40,000 $643,500 $1,086,894 $71,918 $15,658 $2,002,856
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1347178/000134717821000008/vnda-20210422xdef14a.htm

Vanda Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 96,200 units sold on December 2, 2021 by Mihael Polymeropoulos worth over $1.56M
  • In the last 15 years, insiders at Vanda Pharmaceuticals Inc sold an estimated value of $294.85M and bought an estimated value of $28.12M
  • The most active traders are Mihael Polymeropoulos, President and CEO,  James P. Kelly, EVP & Chief Financial Officer,  and Argeris N Karabelas, Director
  • Insider trading is most common in June, with the busiest year in 2006

Vanda Pharmaceuticals Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1